{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T20:31:38Z","timestamp":1793305898587,"version":"4.5.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:00:00Z","timestamp":1775692800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T00:00:00Z","timestamp":1779840000000},"content-version":"vor","delay-in-days":48,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Scientific Research Fundation of Taizhou Enze Medical Center Grant (","award":["24EZCG02"],"award-info":[{"award-number":["24EZCG02"]}],"id":[{"id":"https:\/\/ror.org\/05m0wv206","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100017594","name":"Medical Science and Technology Project of Zhejiang Province (","doi-asserted-by":"crossref","award":["2024KY1788"],"award-info":[{"award-number":["2024KY1788"]}],"id":[{"id":"10.13039\/501100017594","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Zhejiang medical and health science and technology plan project\uff08","award":["2025KY1812"],"award-info":[{"award-number":["2025KY1812"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cancer"],"DOI":"10.1186\/s12943-026-02652-3","type":"journal-article","created":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T23:23:16Z","timestamp":1775690596000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["TRIM29 promotes pancreatic cancer MVI via I\u03baB\u03b1 K48-ubiquitination and NF-\u03baB activation in CXCL5\u207a epithelial cells"],"prefix":"10.1186","volume":"25","author":[{"given":"Long","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenzhen","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wangyang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenbo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaowei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,9]]},"reference":[{"issue":"1","key":"2652_CR1","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3322\/caac.21871","volume":"75","author":"RL Siegel","year":"2025","unstructured":"Siegel RL, Kratzer TB, Giaquinto AN, et al. Cancer statistics, 2025. CA Cancer J Clin. 2025;75(1):10\u201345. https:\/\/doi.org\/10.3322\/caac.21871.","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"2652_CR2","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1002\/cac2.12399","volume":"43","author":"Q Lin","year":"2023","unstructured":"Lin Q, Zheng S, Yu X, et al. Standard pancreatoduodenectomy versus extended pancreatoduodenectomy with modified retroperitoneal nerve resection in patients with pancreatic head cancer: a multicenter randomized controlled trial. Cancer Commun (Lond). 2023;43(2):257\u201375. https:\/\/doi.org\/10.1002\/cac2.12399.","journal-title":"Cancer Commun (Lond)"},{"issue":"9","key":"2652_CR3","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.crad.2023.05.007.10.1016\/j.crad.2023.05","volume":"78","author":"C Jiang","year":"2023","unstructured":"Jiang C, Yuan Y, Gu B, et al. Preoperative prediction of microvascular invasion and perineural invasion in pancreatic ductal adenocarcinoma with 18F-FDG PET\/CT radiomics analysis. Clin Radiol. 2023;78(9):687\u201396. https:\/\/doi.org\/10.1016\/j.crad.2023.05.007.","journal-title":"Clin Radiol"},{"issue":"1","key":"2652_CR4","doi-asserted-by":"publisher","first-page":"166852","DOI":"10.1016\/j.bbadis.2023.166852","volume":"1870","author":"F Ge","year":"2024","unstructured":"Ge F, Zeng C, Wang J, et al. Cancer-associated fibroblasts drive early pancreatic cancer cell invasion via the SOX4\/MMP11 signalling axis. Biochim Biophys Acta Mol Basis Dis. 2024;1870(1):166852. https:\/\/doi.org\/10.1016\/j.bbadis.2023.166852.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"6","key":"2652_CR5","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1016\/j.jhep.2024.06.018.10.1016\/j.jhep.2024.06.0","volume":"81","author":"C Fuster-Anglada","year":"2024","unstructured":"Fuster-Anglada C, Mauro E, Ferrer-F\u00e0brega J, et al. Histological predictors of aggressive recurrence of hepatocellular carcinoma after liver resection. J Hepatol. 2024;81(6):995\u20131004. https:\/\/doi.org\/10.1016\/j.jhep.2024.06.018.","journal-title":"J Hepatol"},{"issue":"8","key":"2652_CR6","doi-asserted-by":"publisher","first-page":"4992","DOI":"10.1245\/s10434-022-11628-8","volume":"29","author":"H Kubo","year":"2022","unstructured":"Kubo H, Ohgi K, Sugiura T, et al. The Association Between Neoadjuvant Therapy and Pathological Outcomes in Pancreatic Cancer Patients After Resection: Prognostic Significance of Microscopic Venous Invasion. Ann Surg Oncol. 2022;29(8):4992\u20135002. https:\/\/doi.org\/10.1245\/s10434-022-11628-8.","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"2652_CR7","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/j.ccell.2024.03.005","volume":"42","author":"N Niu","year":"2024","unstructured":"Niu N, Shen X, Wang Z, et al. Tumor cell-intrinsic epigenetic dysregulation shapes cancer-associated fibroblasts heterogeneity to metabolically support pancreatic cancer. Cancer Cell. 2024;42(5):869\u2013e8849. https:\/\/doi.org\/10.1016\/j.ccell.2024.03.005.","journal-title":"Cancer Cell"},{"issue":"8","key":"2652_CR8","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1016\/j.cell.2023.02.014","volume":"186","author":"CJ Halbrook","year":"2023","unstructured":"Halbrook CJ, Lyssiotis CA, Pasca di Magliano M, et al. Pancreatic cancer: Advances and challenges. Cell. 2023;186(8):1729\u201354. https:\/\/doi.org\/10.1016\/j.cell.2023.02.014.","journal-title":"Cell"},{"issue":"10","key":"2652_CR9","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1016\/j.ccell.2022.09.009","volume":"40","author":"B Ghaddar","year":"2022","unstructured":"Ghaddar B, Biswas A, Harris C, et al. Tumor microbiome links cellular programs and immunity in pancreatic cancer. Cancer Cell. 2022;40(10):1240\u2013e12535. https:\/\/doi.org\/10.1016\/j.ccell.2022.09.009.","journal-title":"Cancer Cell"},{"issue":"6","key":"2652_CR10","doi-asserted-by":"publisher","first-page":"e2205395","DOI":"10.1002\/advs.202205395","volume":"10","author":"YM Liu","year":"2023","unstructured":"Liu YM, Ge JY, Chen YF, et al. Combined Single-Cell and Spatial Transcriptomics Reveal the Metabolic Evolvement of Breast Cancer during Early Dissemination. Adv Sci (Weinh). 2023;10(6):e2205395. https:\/\/doi.org\/10.1002\/advs.202205395.","journal-title":"Adv Sci (Weinh)"},{"issue":"5","key":"2652_CR11","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.ccell.2025.03.004","volume":"43","author":"Y Liu","year":"2025","unstructured":"Liu Y, Sinjab A, Min J, et al. Conserved spatial subtypes and cellular neighborhoods of cancer-associated fibroblasts revealed by single-cell spatial multi-omics. Cancer Cell. 2025;43(5):905\u2013e9246. https:\/\/doi.org\/10.1016\/j.ccell.2025.03.004.","journal-title":"Cancer Cell"},{"key":"2652_CR12","doi-asserted-by":"publisher","first-page":"216149","DOI":"10.1016\/j.canlet.2023.216149.10.1016\/j.canlet.202","volume":"561","author":"Q Yi","year":"2023","unstructured":"Yi Q, Wang J, Liu T, et al. scRNA-Seq and imaging mass cytometry analyses unveil iNKT cells-mediated anti-tumor immunity in pancreatic cancer liver metastasis. Cancer Lett. 2023;561:216149. https:\/\/doi.org\/10.1016\/j.canlet.2023.216149.","journal-title":"Cancer Lett"},{"issue":"3","key":"2652_CR13","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/s41587-019-0392-8","volume":"38","author":"R Moncada","year":"2020","unstructured":"Moncada R, Barkley D, Wagner F, et al. Integrating microarray-based spatial transcriptomics and single-cell RNA-seq reveals tissue architecture in pancreatic ductal adenocarcinomas. Nat Biotechnol. 2020;38(3):333\u201342. https:\/\/doi.org\/10.1038\/s41587-019-0392-8.","journal-title":"Nat Biotechnol"},{"issue":"10","key":"2652_CR14","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1038\/s41576-021-00370-8","volume":"22","author":"SK Longo","year":"2021","unstructured":"Longo SK, Guo MG, Ji AL, et al. Integrating single-cell and spatial transcriptomics to elucidate intercellular tissue dynamics. Nat Rev Genet. 2021;22(10):627\u201344. https:\/\/doi.org\/10.1038\/s41576-021-00370-8.","journal-title":"Nat Rev Genet"},{"issue":"8","key":"2652_CR15","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1016\/j.ccell.2021.05.005","volume":"39","author":"KP Simeonov","year":"2021","unstructured":"Simeonov KP, Byrns CN, Clark ML, et al. Single-cell lineage tracing of metastatic cancer reveals selection of hybrid EMT states. Cancer Cell. 2021;39(8):1150\u2013e11629. https:\/\/doi.org\/10.1016\/j.ccell.2021.05.005.","journal-title":"Cancer Cell"},{"key":"2652_CR16","doi-asserted-by":"publisher","unstructured":"Alonso-Nocelo M, Ruiz-Ca\u00f1as L, Sancho P et al. Macrophages direct cancer cells through a LOXL2-mediated metastatic cascade in pancreatic ductal adenocarcinoma. Gut. 2023;72(2):345\u2013359. 10.1136\/gutjnl-2021-325564. Epub 2022 Apr 15. Erratum in: Gut. 2024, 3(10):e21. https:\/\/doi.org\/10.1136\/gutjnl-2021-325564corr1.","DOI":"10.1136\/gutjnl-2021-325564corr1"},{"issue":"3","key":"2652_CR17","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1002\/cac2.12138.10.1002\/cac2.12138","volume":"41","author":"G Pan","year":"2021","unstructured":"Pan G, Liu Y, Shang L, et al. EMT-associated microRNAs and their roles in cancer stemness and drug resistance. Cancer Commun (Lond). 2021;41(3):199\u2013217. https:\/\/doi.org\/10.1002\/cac2.12138.","journal-title":"Cancer Commun (Lond)"},{"issue":"4","key":"2652_CR18","doi-asserted-by":"publisher","first-page":"467","DOI":"10.3390\/medicina58040467","volume":"58","author":"A Gulla","year":"2022","unstructured":"Gulla A, Andriusaityte U, Zdanys GT, et al. The Impact of Epithelial-Mesenchymal Transition and Metformin on Pancreatic Cancer Chemoresistance: A Pathway towards Individualized Therapy. Med (Kaunas). 2022;58(4):467. https:\/\/doi.org\/10.3390\/medicina58040467.","journal-title":"Med (Kaunas)"},{"issue":"6","key":"2652_CR19","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.7150\/ijbs.76756.10.7150\/ijbs.76","volume":"19","author":"Q Ji","year":"2023","unstructured":"Ji Q, Li H, Cai Z, et al. PYGL-mediated glucose metabolism reprogramming promotes EMT phenotype and metastasis of pancreatic cancer. Int J Biol Sci. 2023;19(6):1894\u2013909. https:\/\/doi.org\/10.7150\/ijbs.76756.","journal-title":"Int J Biol Sci"},{"issue":"1","key":"2652_CR20","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s10020-022-00509-1.10.1186\/s10020-022-00509","volume":"28","author":"Z Zhang","year":"2022","unstructured":"Zhang Z, Xu Y, et al. FZD7 accelerates hepatic metastases in pancreatic cancer by strengthening EMT and stemness associated with TGF-\u03b2\/SMAD3 signaling. Mol Med. 2022;28(1):82. https:\/\/doi.org\/10.1186\/s10020-022-00509-1.","journal-title":"Mol Med"},{"issue":"1","key":"2652_CR21","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s40164-022-00322-w","volume":"11","author":"N Huang","year":"2022","unstructured":"Huang N, Sun X, Li P, et al. TRIM family contribute to tumorigenesis, cancer development, and drug resistance. Exp Hematol Oncol. 2022;11(1):75. https:\/\/doi.org\/10.1186\/s40164-022-00322-w.","journal-title":"Exp Hematol Oncol"},{"issue":"1","key":"2652_CR22","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.mucimm.2024.10.004","volume":"18","author":"J Wang","year":"2025","unstructured":"Wang J, Wang L, Lu W, et al. TRIM29 controls enteric RNA virus-induced intestinal inflammation by targeting NLRP6 and NLRP9b signaling pathways. Mucosal Immunol. 2025;18(1):135\u201350. https:\/\/doi.org\/10.1016\/j.mucimm.2024.10.004.","journal-title":"Mucosal Immunol"},{"key":"2652_CR23","doi-asserted-by":"publisher","first-page":"216510","DOI":"10.1016\/j.canlet.2023.216510","volume":"581","author":"T Jiang","year":"2024","unstructured":"Jiang T, Xia Y, Li Y, et al. TRIM29 promotes antitumor immunity through enhancing IGF2BP1 ubiquitination and subsequent PD-L1 downregulation in gastric cancer. Cancer Lett. 2024;581:216510. https:\/\/doi.org\/10.1016\/j.canlet.2023.216510.","journal-title":"Cancer Lett"},{"key":"2652_CR24","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.canlet.2021.12.029","volume":"529","author":"HY Qiao","year":"2022","unstructured":"Qiao HY, Zhang Q, Wang JM, et al. TRIM29 regulates the SETBP1\/SET\/PP2A axis via transcription factor VEZF1 to promote progression of ovarian cancer. Cancer Lett. 2022;529:85\u201399. https:\/\/doi.org\/10.1016\/j.canlet.2021.12.029.","journal-title":"Cancer Lett"},{"issue":"1","key":"2652_CR25","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s13046-019-1098-y","volume":"38","author":"J Sun","year":"2019","unstructured":"Sun J, Zhang T, Cheng M, et al. TRIM29 facilitates the epithelial-to-mesenchymal transition and the progression of colorectal cancer via the activation of the Wnt\/\u03b2-catenin signaling pathway. J Exp Clin Cancer Res. 2019;38(1):104. https:\/\/doi.org\/10.1186\/s13046-019-1098-y.","journal-title":"J Exp Clin Cancer Res"},{"key":"2652_CR26","doi-asserted-by":"publisher","first-page":"101079","DOI":"10.1016\/j.drup.2024.101079","volume":"74","author":"W Huang","year":"2024","unstructured":"Huang W, Hu X, He X, et al. TRIM29 facilitates gemcitabine resistance via MEK\/ERK pathway and is modulated by circRPS29\/miR-770-5p axis in PDAC. Drug Resist Updat. 2024;74:101079. https:\/\/doi.org\/10.1016\/j.drup.2024.101079.","journal-title":"Drug Resist Updat"},{"issue":"1","key":"2652_CR27","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1186\/s12967-021-03007-w","volume":"19","author":"X Deng","year":"2021","unstructured":"Deng X, Fu X, Teng H, et al. E3 ubiquitin ligase TRIM29 promotes pancreatic cancer growth and progression via stabilizing Yes-associated protein 1. J Transl Med. 2021;19(1):332. https:\/\/doi.org\/10.1186\/s12967-021-03007-w.","journal-title":"J Transl Med"},{"issue":"12","key":"2652_CR28","doi-asserted-by":"publisher","first-page":"2742","DOI":"10.1038\/s41596-018-0073-y","volume":"13","author":"A Lafzi","year":"2018","unstructured":"Lafzi A, Moutinho C, Picelli S, et al. Tutorial: guidelines for the experimental design of single-cell RNA sequencing studies. Nat Protoc. 2018;13(12):2742\u201357. https:\/\/doi.org\/10.1038\/s41596-018-0073-y.","journal-title":"Nat Protoc"},{"issue":"7","key":"2652_CR29","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1016\/j.cell.2017.10.044","volume":"171","author":"SV Puram","year":"2017","unstructured":"Puram SV, Tirosh I, Parikh AS, et al. Single-Cell Transcriptomic Analysis of Primary and Metastatic Tumor Ecosystems in Head and Neck Cancer. Cell. 2017;171(7):1611\u2013e162424. https:\/\/doi.org\/10.1016\/j.cell.2017.10.044.","journal-title":"Cell"},{"issue":"3","key":"2652_CR30","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1038\/s41591-023-02786-7","volume":"30","author":"K Wang","year":"2024","unstructured":"Wang K, Xiang YJ, Yu HM, et al. Adjuvant sintilimab in resected high-risk hepatocellular carcinoma: a randomized, controlled, phase 2 trial. Nat Med. 2024;30(3):708\u201315. https:\/\/doi.org\/10.1038\/s41591-023-02786-7.","journal-title":"Nat Med"},{"issue":"10485","key":"2652_CR31","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1016\/S0140-6736(25)00261-2","volume":"405","author":"TF Stoop","year":"2025","unstructured":"Stoop TF, Javed AA, Oba A, et al. Pancreatic cancer. Lancet. 2025;405(10485):1182\u2013202. https:\/\/doi.org\/10.1016\/S0140-6736(25)00261-2.","journal-title":"Lancet"},{"issue":"1","key":"2652_CR32","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/s41420-023-01491-1","volume":"9","author":"Q Yi","year":"2023","unstructured":"Yi Q, Zhao Y, Xia R, et al. TRIM29 hypermethylation drives esophageal cancer progression via suppression of ZNF750. Cell Death Discov. 2023;9(1):191. https:\/\/doi.org\/10.1038\/s41420-023-01491-1.","journal-title":"Cell Death Discov"},{"issue":"1","key":"2652_CR33","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1186\/s12964-025-02233-9","volume":"23","author":"Q Wu","year":"2025","unstructured":"Wu Q, Siddharth S, Verma D, et al. TRIM29 upregulation contributes to chemoresistance in triple negative breast cancer via modulating S100P-\u03b2-catenin axis. Cell Commun Signal. 2025;23(1):244. https:\/\/doi.org\/10.1186\/s12964-025-02233-9.","journal-title":"Cell Commun Signal"},{"issue":"1","key":"2652_CR34","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/s41392-024-01757-9","volume":"9","author":"Q Guo","year":"2024","unstructured":"Guo Q, Jin Y, Chen X, et al. NF-\u03baB in biology and targeted therapy: new insights and translational implications. Signal Transduct Target Ther. 2024;9(1):53. https:\/\/doi.org\/10.1038\/s41392-024-01757-9.","journal-title":"Signal Transduct Target Ther"},{"issue":"9","key":"2652_CR35","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1016\/j.cell.2024.03.022","volume":"187","author":"BL Lampson","year":"2024","unstructured":"Lampson BL, Ram\u03afrez AS, Baro M, et al. Positive selection CRISPR screens reveal a druggable pocket in an oligosaccharyltransferase required for inflammatory signaling to NF-\u03baB. Cell. 2024;187(9):2209\u2013e222316. https:\/\/doi.org\/10.1016\/j.cell.2024.03.022.","journal-title":"Cell"},{"key":"2652_CR36","doi-asserted-by":"publisher","first-page":"117552","DOI":"10.1016\/j.biopha.2024.117552.10.1016\/j.biopha.2","volume":"180","author":"P Poma","year":"2024","unstructured":"Poma P, Rigogliuso S, Labbozzetta M, et al. Antimigratory effects of a new NF-\u03baB inhibitor, (S)-b-salicyloylamino-a-exo-methylene-\u01b4-butyrolactone, in 2D and 3D breast cancer models. Biomed Pharmacother. 2024;180:117552. https:\/\/doi.org\/10.1016\/j.biopha.2024.117552.","journal-title":"Biomed Pharmacother"}],"container-title":["Molecular Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12943-026-02652-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-026-02652-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-026-02652-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T23:31:39Z","timestamp":1779838299000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12943-026-02652-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,9]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2652"],"URL":"https:\/\/doi.org\/10.1186\/s12943-026-02652-3","relation":{},"ISSN":["1476-4598"],"issn-type":[{"value":"1476-4598","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,9]]},"assertion":[{"value":"18 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from all patients, and the study adhered to the guidelines of the Ethics Committee of the Second Affiliated Hospital of Zhejiang University (Ethics No: 2024-0547). All animal experiments were approved by the Animal Research Committee of the Ethics Committee of the Second Affiliated Hospital of Zhejiang University (Ethics: 2024-397).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"145"}}